Moneycontrol

You are Here : Margins may be hit on one-off items in EBITDA: Sun Pharma

Wednesday, 05:04

Uday Baldota, VP- investor relations, Sun Pharma tells CNBC-TV18 that apart from the drug Taro’s stellar contribution, other business segments also performed well
MAY 23, 2017
01:06 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On